| 000 | 01561 a2200433 4500 | ||
|---|---|---|---|
| 005 | 20250516003820.0 | ||
| 264 | 0 | _c20110121 | |
| 008 | 201101s 0 0 eng d | ||
| 022 | _a1875-7855 | ||
| 024 | 7 |
_a10.1016/S0079-6123(10)84007-5 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aFox, Susan H | |
| 245 | 0 | 0 |
_aThe MPTP-lesioned non-human primate models of Parkinson's disease. Past, present, and future. _h[electronic resource] |
| 260 |
_bProgress in brain research _c2010 |
||
| 300 |
_a133-57 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntiparkinson Agents _xtoxicity |
| 650 | 0 | 4 |
_aBasal Ganglia _xpathology |
| 650 | 0 | 4 |
_aCognition Disorders _xchemically induced |
| 650 | 0 | 4 | _aDisease Models, Animal |
| 650 | 0 | 4 |
_aDopamine _xphysiology |
| 650 | 0 | 4 | _aDrug Discovery |
| 650 | 0 | 4 | _aEndpoint Determination |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLevodopa _xtoxicity |
| 650 | 0 | 4 |
_aMPTP Poisoning _xpathology |
| 650 | 0 | 4 |
_aMovement _xphysiology |
| 650 | 0 | 4 |
_aNeurons _xpathology |
| 650 | 0 | 4 |
_aNeuroprotective Agents _xpharmacology |
| 650 | 0 | 4 |
_aParkinson Disease, Secondary _xchemically induced |
| 650 | 0 | 4 | _aPrimates |
| 650 | 0 | 4 |
_aPsychoses, Substance-Induced _xetiology |
| 650 | 0 | 4 |
_aSleep Wake Disorders _xchemically induced |
| 650 | 0 | 4 |
_aalpha-Synuclein _xgenetics |
| 700 | 1 | _aBrotchie, Jonathan M | |
| 773 | 0 |
_tProgress in brain research _gvol. 184 _gp. 133-57 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/S0079-6123(10)84007-5 _zAvailable from publisher's website |
| 999 |
_c20215914 _d20215914 |
||